BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• DAKOTA Life Sciences Employing Blockchain Technology for New Global Pharmaceutical Security and Drug Resistance Monitoring

  Kasten Dakota Life Sciences has adopted blockchain technology for its new global drug protection software and information technology suite.

  December 21, 2017

   · 

  2 min read
• Drug Development

  Trovagene Announces Activation of Second Clinical Trial Site in Phase Ib/II AML Trial for PCM-075

  This trial is being led by Hematologist Jorge Eduardo Cortes, M.D., Deputy Department Chair, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center.

  December 21, 2017

   · 

  8 min read
• Policy

  KindredBio Announces Submission of EMA Filing for Mirataz

  The EMA has accepted the submission for review, with the official acceptance date of December 21, 2017.

  December 21, 2017

   · 

  4 min read
• Mundipharma Uses Thinfilm’s NFC Solution to Generate Consumer Awareness for New Cold-Prevention Medication

  Beginning in December, Mundipharma will leverage Thinfilm’s complete NFC solution to deploy and manage a consumer-focused mobile marketing campaign promoting its BETADINE Cold Defence nasal spray product.

  December 21, 2017

   · 

  4 min read
• Policy

  NuVasive Comments on Expected Impact of U.S. Tax Reform

  Based on the preliminary assessment of the legislation, the Company believes the new regulations will positively impact its non-GAAP EPS.

  December 21, 2017

   · 

  4 min read
• Business

  Invitae Chairman Randy Scott Joins Freenome Board of Directors

  For nearly three decades, Dr. Scott has been an entrepreneur and visionary leader in genomic medicine.

  December 21, 2017

   · 

  2 min read
• 

  Business

  Kolon Life Science Faces More Headwinds on Its Gene Therapy As Partner Seeks to Cancel Deal

  Kolon Life Science is facing more headwinds on its gene therapy for degenerative arthritis as a Japanese partner seeks to cancel a license deal signed last year due to negligent reporting on issues related to the late-stage drug candidate.

  December 21, 2017

   · 

  1 min read
• 

  Business

  PENTAX Medical Names Veteran Executive as The Americas Region President and CEO

  PENTAX Medical announced that David Woods, the current Global CMO of PENTAX Medical, has been appointed President of PENTAX Medical of the Americas, effective immediately.

  December 21, 2017

   · 

  2 min read
• 

  Business

  Zomedica, Celsee Ink Deal For Cancer Liquid Biopsy Platform

  Zomedica today announced it has entered into a license and supply agreement with Celsee.

  December 21, 2017

   · 

  8 min read
• Drug Development

  FDA Grants RMAT Designation For Mesoblast’s Cell Therapy in Heart Failure Patients With LVADs

  The RMAT designation under the 21st Century Cures Act aims to expedite the development of regenerative medicine therapies intended for the treatment of serious diseases and life-threatening conditions.

  December 21, 2017

   · 

  8 min read